Optimal drug prediction from personal genomics profiles

Area of Science:

• Computational biology
• Genomics
• Pharmacogenomics

Background:

• Cancer patients exhibit diverse responses to anticancer drugs, with only a subset showing sensitivity.
• Genomic profiling (whole transcriptome and genome) via next-generation sequencing is feasible for identifying genetic variations linked to drug response heterogeneity.
• Current subtyping analyses identify patient subgroups but lack precise individual drug response prediction methods.

Purpose of the Study:

• To develop a novel computational algorithm for predicting individual patient drug response.
• To leverage personal genomic profiles, pharmacogenomic, and drug sensitivity data for accurate prediction.
• To enhance the reliability of identifying optimal anticancer drugs for individual cancer patients.

Main Methods:

• Utilized data from the Genomics of Drug Sensitivity in Cancer database, including over 600 cancer cell lines and responses to 75 drugs.
• Determined drug-specific sensitivity signatures from genomic profile changes in response to specific drugs.
• Predicted optimal drugs for individual cell lines by integrating voting from other cell lines.

Main Results:

• The developed drug prediction algorithm significantly improves the reliability of identifying optimal drugs for individual patients.
• Demonstrated the algorithm's capability to predict drug responses based on personal genomic data.
• The approach shows promise for integration into precision medicine frameworks.

Conclusions:

• The proposed computational algorithm offers a reliable method for predicting individual anticancer drug responses.
• This tool is a key component for advancing precision medicine in oncology care.
• Personalized genomic profiles combined with this algorithm can guide optimal drug selection for cancer patients.